Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Chinese Journal of Hepatology

1993  to  Present  ISSN: 1007-3418

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

5781

results

page

of 579

1

Cite

Cite

Copy

Share

Share

Copy

Expression and significance of erb-B receptor family in hepatocellular carcinoma.

Ji CAO ; Yin-Nong ZHAO ; Fei-Xiang WU ; Chao OU ; Ke-Chen BAN ; Wei WEI ; Yuan LI ; Jian-Jia SU ; An-Min LIANG

Chinese Journal of Hepatology.2005;13(2):146-147.


Adult ; Aged ; Carcinoma, Hepatocellular ; metabolism ; Female ; Humans ; Liver Neoplasms ; metabolism ; Male ; Middle Aged ; RNA, Messenger ; biosynthesis ; genetics ; Receptor, ErbB-2 ; biosynthesis ; genetics ; Receptor, ErbB-3 ; biosynthesis ; genetics

Adult ; Aged ; Carcinoma, Hepatocellular ; metabolism ; Female ; Humans ; Liver Neoplasms ; metabolism ; Male ; Middle Aged ; RNA, Messenger ; biosynthesis ; genetics ; Receptor, ErbB-2 ; biosynthesis ; genetics ; Receptor, ErbB-3 ; biosynthesis ; genetics

2

Cite

Cite

Copy

Share

Share

Copy

Pexoxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.

Yan-Tong GUO ; Xi-Sheng LENG ; Jing-Ming ZHAO ; Xi-Hou LIN ; Tao LI ; Ji-Ye ZHU

Chinese Journal of Hepatology.2005;13(2):145-146.


Animals ; Antineoplastic Agents ; therapeutic use ; Chromans ; therapeutic use ; Diethylnitrosamine ; Ligands ; Liver Neoplasms, Experimental ; chemically induced ; drug therapy ; Male ; PPAR gamma ; biosynthesis ; genetics ; Rats ; Rats, Wistar ; Thiazolidinediones ; therapeutic use

Animals ; Antineoplastic Agents ; therapeutic use ; Chromans ; therapeutic use ; Diethylnitrosamine ; Ligands ; Liver Neoplasms, Experimental ; chemically induced ; drug therapy ; Male ; PPAR gamma ; biosynthesis ; genetics ; Rats ; Rats, Wistar ; Thiazolidinediones ; therapeutic use

3

Cite

Cite

Copy

Share

Share

Copy

The application of Bletilla striata in the interventional therapy of hepatocellular carcinoma: a comparative study using ACI rats.

Jun QIAN ; Zhuan-Sheng ZHENG ; Han-Ping WU ; Wei-Yong LI ; Daryusch VOSSOUGHI ; Oppermann ELSIE ; Vogl THOMAS ; Gan-Sheng FENG

Chinese Journal of Hepatology.2005;13(2):143-144.


Animals ; Chemoembolization, Therapeutic ; Drugs, Chinese Herbal ; administration & dosage ; Iodized Oil ; administration & dosage ; Liver Neoplasms, Experimental ; therapy ; Mitomycin ; administration & dosage ; Orchidaceae ; Phytotherapy ; Rats ; Rats, Inbred ACI

Animals ; Chemoembolization, Therapeutic ; Drugs, Chinese Herbal ; administration & dosage ; Iodized Oil ; administration & dosage ; Liver Neoplasms, Experimental ; therapy ; Mitomycin ; administration & dosage ; Orchidaceae ; Phytotherapy ; Rats ; Rats, Inbred ACI

4

Cite

Cite

Copy

Share

Share

Copy

The level of serum thrombopoietin in patients with chronic hepatic diseases suffering from thrombocytopenia.

Yu-Tao XIE ; Xiao-Hua JIANG ; De-Ming TAN

Chinese Journal of Hepatology.2005;13(2):142-143.


Adolescent ; Adult ; Aged ; Female ; Hepatitis, Chronic ; blood ; complications ; Humans ; Male ; Middle Aged ; Thrombocytopenia ; blood ; etiology ; Thrombopoietin ; blood

Adolescent ; Adult ; Aged ; Female ; Hepatitis, Chronic ; blood ; complications ; Humans ; Male ; Middle Aged ; Thrombocytopenia ; blood ; etiology ; Thrombopoietin ; blood

5

Cite

Cite

Copy

Share

Share

Copy

Evaluation of treatments for nonalcoholic fatty liver disease.

You-Ming LI

Chinese Journal of Hepatology.2005;13(2):141-141.


Diet, Reducing ; Exercise ; Fatty Liver ; therapy ; Humans

Diet, Reducing ; Exercise ; Fatty Liver ; therapy ; Humans

6

Cite

Cite

Copy

Share

Share

Copy

Abstinence and fatty liver.

Bing-Yuan WANG

Chinese Journal of Hepatology.2005;13(2):140-140.


Alcohol Deterrents ; therapeutic use ; Alcohol Drinking ; therapy ; Fatty Liver ; therapy ; Fatty Liver, Alcoholic ; therapy ; Humans

Alcohol Deterrents ; therapeutic use ; Alcohol Drinking ; therapy ; Fatty Liver ; therapy ; Fatty Liver, Alcoholic ; therapy ; Humans

7

Cite

Cite

Copy

Share

Share

Copy

Drug therapy for nonalcoholic fatty liver disease.

Wei SHEN

Chinese Journal of Hepatology.2005;13(2):139-139.


Antioxidants ; therapeutic use ; Fatty Liver ; drug therapy ; Humans ; Hypoglycemic Agents ; therapeutic use ; Hypolipidemic Agents ; therapeutic use ; Metformin ; therapeutic use ; Quaternary Ammonium Compounds ; therapeutic use ; Vitamin E ; therapeutic use

Antioxidants ; therapeutic use ; Fatty Liver ; drug therapy ; Humans ; Hypoglycemic Agents ; therapeutic use ; Hypolipidemic Agents ; therapeutic use ; Metformin ; therapeutic use ; Quaternary Ammonium Compounds ; therapeutic use ; Vitamin E ; therapeutic use

8

Cite

Cite

Copy

Share

Share

Copy

Treatment of nonalcoholic fatty liver disease: behavior modification, diet therapy and exercise programs.

Lun-Gen LU ; Min-de ZENG

Chinese Journal of Hepatology.2005;13(2):138-138.


Behavior Therapy ; Diet, Reducing ; Exercise ; Fatty Liver ; diet therapy ; therapy ; Female ; Humans ; Male

Behavior Therapy ; Diet, Reducing ; Exercise ; Fatty Liver ; diet therapy ; therapy ; Female ; Humans ; Male

9

Cite

Cite

Copy

Share

Share

Copy

Current therapeutic strategy of fatty liver diseases.

Jian-Gao FAN

Chinese Journal of Hepatology.2005;13(2):136-137.


Fatty Liver ; therapy ; Fatty Liver, Alcoholic ; therapy ; Female ; Humans ; Male

Fatty Liver ; therapy ; Fatty Liver, Alcoholic ; therapy ; Female ; Humans ; Male

10

Cite

Cite

Copy

Share

Share

Copy

Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis.

Yan WANG ; Ying-Ji MA ; Bao-Shan YANG ; Man-Ru BI ; Li-Yan CHEN

Chinese Journal of Hepatology.2005;13(2):132-135.

OBJECTIVEApoptosis of the cells of liver cancer cell line HepG2 could be induced by TNF alpha and actinomycin D (Act D). In the current study, the molecular mechanism of the apoptosis protection of stronger neo-minophagen C (SNMC) to HepG2 cells was investigated.

METHODSSNMC was added to the HepG2 cell culture medium when the cell concentration reached 0, 2, 20, 100, 200, 800 microg/ml 30 min before their apoptosis were inducted with TNF alpha and Act D. A flow cytometry assay was performed to detect the cell apoptosis rate; electromicroscopy was employed to visualize the subcellular structure after apoptosis. DNA ladder formation was checked with genomic DNA agarose electrophoresis. The expression pattern of apoptosis related protein Caspase-3, Bcl-2 and Bax was detected by Western blot.

RESULTSAfter pretreatment with various concentrations of SNMC and 12 hours after treatment with TNF alpha and Act D, the HepG2 cell apoptosis rate and DNA ladder formation decreased dramatically when the SNMC concentration was higher in the media; the intracellular inactive form of Caspase-3 increased while the 17*10(3) active Caspase-3 decreased gradually. In addition, the expression of Bcl-2 increased and the expression of Bax decreased. Under the electromicroscope, the typical nucleolus condensation of HepG2 induced by TNF alpha and Act D was not seen among the 100 microg/ml SNMC treated cells.

CONCLUSIONSNMC inhibits TNF alpha and Act D induced HepG2 cell apoptosis. This protective action may be regulated by intracellular apoptosis related factors.


Apoptosis ; drug effects ; Carcinoma, Hepatocellular ; pathology ; Cell Line, Tumor ; Cysteine ; pharmacology ; Drug Combinations ; Glycine ; pharmacology ; Glycyrrhiza ; Humans ; Liver Neoplasms ; pathology ; Oleanolic Acid ; analogs & derivatives ; pharmacology

Apoptosis ; drug effects ; Carcinoma, Hepatocellular ; pathology ; Cell Line, Tumor ; Cysteine ; pharmacology ; Drug Combinations ; Glycine ; pharmacology ; Glycyrrhiza ; Humans ; Liver Neoplasms ; pathology ; Oleanolic Acid ; analogs & derivatives ; pharmacology

Country

China

Publisher

Editorial Department of Journal of Clinical Hepatology

ElectronicLinks

https://zhgzbzz.yiigle.com/

Editor-in-chief

E-mail

zhgz@vip.163.com

Abbreviation

Chinese Journal of Hepatology

Vernacular Journal Title

中华肝脏病杂志

ISSN

1007-3418

EISSN

Year Approved

2008

Current Indexing Status

Currently Indexed

Start Year

1993

Description

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.